The Center for Molecular Cardiology (CMC) was launched in the spring of 2006, with the mission of promoting basic and clinically relevant research on congenital heart defects in children. Drawing on the research strengths at the Icahn School of Medicine, the Center is unique in its scope and scale.

Under the leadership of founding scientific director, Bruce D. Gelb, MD, a pediatric cardiologist who specializes in cardiovascular genetics and heart transplantation, the Center is accomplishing its mission by supporting and facilitating:

• Important discoveries that uncover the causes of congenital and acquired heart problems of childhood.
• Translating laboratory-based findings into healthcare strategies to improve the lives of children with heart problems.
• Training future generations of scientists and physician-scientists to pursue state-of-the-art research relevant to cardiovascular diseases of childhood.
• Educating physicians and other health care professionals, medical and graduate students, families impacted by these disorders, and the general public.